Skip to content

Public FDA record

Z-0565-2021: (1) Capiox FX25 (West) Advance Oxygenator- with left port, 4-liter Reservoir, XC modified to Advance, S

Recall record Z-0565-2021 for Terumo Cardiovascular Systems Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0565-2021
Company in FDA record
Terumo Cardiovascular Systems Corporation
FDA record creation date
Dec 14, 2020
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Capiox FX25 Advance oxygenator may be the incorrect configuration (East vs. West)

Source facts

Action
Terumo issued URGENT Medical Device Removal letter on 11/11/2020 to all end users who have received potentially affected product via 2-day FedEx mailing. The letter states reason for recall, health risk and action to take: Remove of the Capiox FX25 Advance Reservoir/Oxygenator assembly from the cardboard box(es) but keep the unit within the sterile Tyvek pouch bag. " Review the label on the back of the reservoir to determine if the configuration is East or West. " Rotate the unit until the blood outlet port of the oxygenator is facing the observer (blood outlet port is evident by the red cap on the oxygenator port). With the blood outlet port facing the observer, locate the water ports on the end cap of the oxygenator. If the Water ports are facing to the left with the blood outlet port facing the observer, then the unit is an East configuration. If the Water ports are facing to the right with the blood outlet port facing the observer, then the unit is a West configuration (see photos below). " If you identify an incorrectly configured oxygenator, follow the instructions on the response form and contact Terumo CVS to return the device. CUSTOMER INSTRUCTIONS 1. Review this Medical Device Removal and the Recommended Actions and assure that all users receive notice of this issue. 2. Confirm receipt of this communication by completing and returning the attached Customer Response Form as indicated on the form regardless of whether affected product is currently in your facilitys possession or it has been consumed. 3. In the event the affected product has been further distributed, please forward a copy of this notification to the appropriate end user. 4. Respond to Terumo CVS by emailing or faxing the attached Customer Response Form to the email address or fax number indicated on the form. QUESTIONS? We encourage you to contact Terumo CVS with any questions or concerns: Terumo CVS Customer Service: 1.800.521.2818
Initiated
2020-11-11
Root cause
Labeling mix-ups
Terminated
2021-11-22
Distribution
US Nationwide Foreign: Belgium, India
Recall number
Z-0565-2021
Recall status
Terminated
CDRH record ID
184501
FDA record created
2020-12-14
Recall event number
86779

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗